Symptom variability throughout the day in patients with gastroparesis.
Dariush ShahsavariDaohai YuAsad JehangirXiaoning LuBryan ZollHenry P ParkmanPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2019)
Patients with Gp filled Patient Assessment of Gastrointestinal Symptoms (PAGI-SYM) and completed a modified GCSI-DD seven times a day (GCSI-Throughout the Day [GCSI-TTD]; before and after meals, and before going to bed) over a 2-week period. KEY RESULTS: A total of 44 patients participated (86% females), including 29 (66%) with IGp, 13 (30%) with DGp, and 2 (4%) with postsurgical Gp. Using the GCSI-TTD, patients with Gp reported significant postprandial worsening of overall symptom severity, as well as severities of nausea, early satiety, stomach fullness, and abdominal pain. Patients also had progressive worsening of the overall symptom severity, early satiety, stomach fullness, and abdominal pain during the day; however, nausea severity did not differ during the day. Number of vomiting and retching episodes did not show significant variations postprandially or during the day. Patients with IGp had greater symptom severity throughout the day and greater postprandial increase in symptoms compared to patients with DGp. CONCLUSIONS AND INFERENCES: Patients with Gp experience postprandial worsening of overall symptom severity, as well as severities of nausea, early satiety, stomach fullness, and abdominal pain. These symptoms also progressively worsen during the day, except for the severity of nausea which persists throughout the day. Understanding the symptom variability in patients with Gp throughout the day and postprandially may be useful in treatment of patients with Gp.
Keyphrases
- abdominal pain
- patient reported
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- chemotherapy induced
- prognostic factors
- blood glucose
- randomized controlled trial
- type diabetes
- clinical trial
- depressive symptoms
- adipose tissue
- metabolic syndrome
- case report
- patient reported outcomes
- insulin resistance
- combination therapy